Ask the expert
Digital health is a dynamic field with a significant amount of innovation. Digital health technologies include solutions for tele-consultation, remote monitoring, connected devices, digital platforms and health apps.
Sample pages are provided for an older version of the report. Before delivery to the client, the report is updated to the current state (e.g., 2022 coding, tariffs, and policy considerations).
While health apps are becoming of high interest to patients, healthcare providers and payers, it takes time for reimbursement systems to adjust and introduce a payment mechanism for health apps.
Reimbursement is one of the key barriers for the adoption and wide dissemination of health apps.
In this report, the leading European Med Tech consultancy MTRC summarized information about current and future administrative and reimbursement landscape for health apps in the countries with the most advanced payment systems for E-health in Europe.
A syndicated 105-page report includes information on the current administrative framework for health apps, current reimbursement framework, examples of reimbursed apps, the role of health technology assessment, upcoming changes in the reimbursement systems.
Reimbursement information is provided for the following geographies:
- The Netherlands
See more information and obtain sample pages here.
Table of content is not available at the moment. Report is still ongoing.
In February 2023, the Scottish Health Technology Group, SHTG, released three MedTech-related assessments: selective internal radiation therapies (SIRT) for treating primary hepatocellular carcinoma, Feeling Good app, store-and-forward teledermatology for triage of primary care referrals.Read more
In January-February 2023, Health Technology Wales published sixteen Medtech-related Topic Exploration Reports (TER), including stereotactic radiosurgery, percutaneous implantation of pulmonary artery pressure sensors, ambulatory patch ECG devices, and others; however, Health Technology Wales will not proceed with full appraisals on these topics. No Guidance was released for Medtech in January-February 2023.Read more
In March 2023, a new ‘AI and Digital Regulations Service’ for developers and adopters of artificial intelligence (AI) and digital technologies was launched in England. Four organizations provide this multi-agency advisory service: NICE, Care Quality Commission, Medicines and Healthcare products Regulatory Agency, and Health Research Authority. The website is currently in public beta and focused on information for developers.Read more
The Ministry of Health has commissioned the Agency for Health Quality and Assessment of Catalonia (AQuAS) to develop, with the collaboration of the various agencies that make up the Spanish Network of Agencies for the Evaluation of Health Technologies and Benefits (RedETS), a specific methodological framework for the evaluation of digital health technologies that would allow a comprehensive assessment of this type of technology. The methodological framework is in the final phase of development.Read more
In February 2023, the National Institute for Health and Care Excellence (NICE) published two new Interventional Procedure Guidance (transvenous obliteration for gastric varices, biodegradable spacer to reduce rectal toxicity during radiotherapy for prostate cancer), one new Health Technology Evaluation (guided self-help digital cognitive behavioural therapy), and two new Medtech Innovation Briefings (LIVERFASt, and Ambu aScope 4 RhinoLaryngo). Also, one new clinical guideline was published, and one was updated.Read more